EASL Studio S4E17 - Albumin in Cirrhosis: For All, For Some, For None
S4E17 Promo - Albumin in Cirrhosis: For all, some, or none?
EASL Studio - S2 E17 - EASL Haemochromatosis Guidelines 2022
EASL Studio S4E10 - Ascites: New solution for an old problem
EASL Studio S4E1 - Hepatitis B elimination
EASL Studio - Regenerative Hepatology: From stem cells to tissue engineering
EASL Studio - S2E6 - Should anticoagulants be given to patients with cirrhosis to improve outcome?
EASL Studio - Season 1, Episode 2 - The AASLD Liver Meeting
EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?
EASL Studio S3E14 - The future of hepatology
EASL Studio - S3E15 - Chronic portal vein thrombosis
EASL Studio - S3E16 - Liver cancer in 2022: Wrap-up & outlook
S4E19 Promo - HDV: The devil becomes treatable
S4E22 PROMO - JHEP Live: New and promising drugs for NASH on the horizon
EASL Congress 2023 - Explore the General Hepatology Track!
Mirum PFIC Series: Cedar
EASL Congress 2023 in THREE WORDS!
ILC 2018 Debrief : Cirrhosis and Complications
APASL Hepatology Webinar
EASL Congress 2023 - Opening Press Conference
